(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual revenue growth rate of 30.72% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Ekso Bionics Holdings's revenue in 2024 is $18,279,000.On average, 1 Wall Street analysts forecast EKSO's revenue for 2024 to be $420,723,508, with the lowest EKSO revenue forecast at $420,723,508, and the highest EKSO revenue forecast at $420,723,508. On average, 1 Wall Street analysts forecast EKSO's revenue for 2025 to be $546,045,404, with the lowest EKSO revenue forecast at $546,045,404, and the highest EKSO revenue forecast at $546,045,404.
In 2026, EKSO is forecast to generate $730,984,716 in revenue, with the lowest revenue forecast at $730,984,716 and the highest revenue forecast at $730,984,716.